Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Embracing Future HoldingsSGX:8YY -7.14% Days Inventory is 0.00 as of Dec. 2025. The stock has 5 warning signs investors should review. Among 178 Medical Diagnostics & Research companies, Embracing Future Holdings ranks worse than 561797.19% on this metric.
The historical rank and industry rank for Embracing Future Holdings's Days Inventory or its related term are showing as below:
During the past 11 years, Embracing Future Holdings's highest Days Inventory was 825.95. The lowest was 6.73. And the median was 268.25.
SGX:8YY's Days Inventory is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 64.86 * Ranked among companies with meaningful Days Inventory only.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Embracing Future Holdings's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.00.
Embracing Future Holdings (SGX:8YY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Embracing Future Holdings's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Embracing Future Holdings's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Embracing Future Holdings Days Inventory Related Terms
Embracing Future Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:8YY vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Embracing Future Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embracing Future Holdings Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Embracing Future Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Embracing Future Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embracing Future Holdings (SGX:8YY) has a Days Inventory of 0.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Embracing Future Holdings and its competitors. Over the past decade, Embracing Future Holdings' Days Inventory has ranged from 6.73 to 825.95. According to the industry distribution chart, Embracing Future Holdings ranks #999999 out of 178 companies in the Medical Diagnostics & Research industry.
Is Embracing Future Holdings' Days Inventory too high?
Embracing Future Holdings' current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 6.73 to a high of 825.95. Based on the distribution chart, Embracing Future Holdings ranks #999999 out of 178 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Embracing Future Holdings' Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Embracing Future Holdings ranks #999999 out of 178 companies for Days Inventory. This places Embracing Future Holdings in the lower half of its industry. The industry median Days Inventory is 64.86. Historically, Embracing Future Holdings' own Days Inventory has ranged from 6.73 to 825.95 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 64.86, based on 178 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Embracing Future Holdings and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 64.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embracing Future Holdings's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embracing Future Holdings stock overvalued right now?
Embracing Future Holdings (SGX:8YY) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Embracing Future Holdings (SGX:8YY), the current Days Inventory is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Embracing Future Holdings Ltd is engaged in technology development, technology transfer, marketing, sales, and distribution of biomedical technology, life, and medicine science-related products and services, and investment holding. The company's business segments are: Cancer, Infectious Diseases, E-sports, Advertising, and Corporate. The company generates the majority of its revenue from the E-sports segment, which involves identifying and assessing potential collaboration partners, technology, digital platforms, products, and services related to E-Sports. Its operations are spread across Singapore, Japan, China, Europe, Hong Kong, Thailand, Malaysia, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:8YY has been successfully added to your 
